Connect with us

News

Indian Supreme Court to rule on ‘Ayodhya’ dispute

Published

on

Indian Supreme Court To Rule On Ayodhya Dispute | Diya TV News

AYODHYA, India (Diya TV)  — The Indian Supreme Court is expected to issue its verdict on the dispute over the Ram Janmabhoomi / Babri Masjid site in Ayodhya, India on Saturday, November 9th. Indian Prime Minister Narendra Modi said the verdict in this politically sensitive case will “not be a matter of victory or loss,” appealing to his nation to “strengthen India’s great tradition of peace, unity and amity.”

India’s credit rating was cut to negative by Moody’s Investors Service, the first step toward a downgrade, as concerns mount an economic slowdown will be prolonged and debt will rise. Meanwhile, China said it has agreed with the United States to cancel tariffs on each others’ goods in phases, a key demand of Beijing to end a trade war that has affected economic growth globally.

India and China will surpass the U.S. as the World’s Centers of Tech Innovation by 2035, according to Bloomberg New Economy Global Survey, which gathered views from 2,000  business professionals in 20 markets.

And Harsimran Kaur becomes first female player from the NBA Academy’s Women’s Program in India to be invited to The NBA Global Academy.

Ravi Kapur contributed to this report.

News

India agrees to supply Hydroxychloroquine to U.S.

Published

on

Hydroxychloroquine

WASHINGTON (Diya TV)  — India confirmed they will fulfill the order the U.S. made for hydroxychloroquine, just a couple of days after they banned all exports of the malaria treatment without exception. President Trump and Prime Minister Modi spoke about keeping the supply chain intact over the weekend. And India says the U.S. purchase was approved before President Trump said there would be ‘retaliation’ if the drug was not released, medicine that is being used to treat coronavirus patients without definitive evidence it works. India says they have enough hydroxychloroquine stock for its people today, but reserves the right to hold back the supply if their COVID-19 caseload increases.

One day after he defended firing Captain Brett Crozier from command of the USS Theodore Roosevelt by calling him “stupid,” Acting Navy Secretary Thomas Modly resigned. Modly was severely criticized for firing Crozier, after the captain wrote an alarming letter seeking faster assistance for his sailors exposed to COVID-19 on board, a letter that was leaked to the press.

Ravi Kapur contributed to this report.

Continue Reading

News

Trump calls on Modi to supply Hydroxychloroquine

Published

on

Trump

WASHINGTON (Diya TV)  — President Trump spoke to Prime Minister Modi over the weekend about how the two nations would combat the coronavirus, with a focus on ensuring the supply chain for pharmaceuticals and medical goods continues. But at a press conference, when informed India had banned the export of the drug hydroxychloroquine “without any exceptions,” Trump threatened retaliation. Hydroxychloroquine is typically used to treat malaria, but some COVID-19 patients have found it helpful. And the President has been touting it during his press conferences, without a clinical trial proving if it is indeed effective. India provides nearly half of America’s supply of the medicine. It is not clear whether India’s ban would apply to orders already placed.

Prime Minister Modi called on his nation to unite in the battle against COVID-19 by lighting diyas for 9 minutes at 9 pm Sunday night. Millions of people around India took part, which is now entering its third week of being mandated to stay at home to stop the spread of the virus.

Ravi Kapur contributed to this report.

Continue Reading

News

Trump tells India to supply hydroxychloroquine or face ‘retaliation’

Published

on

Trump

During a White House Press briefing, President Trump recounted having a conversation with Indian Prime Minister Modi Sunday morning about the ongoing Coronavirus pandemic. When informed by reporters that Modi was unlikely to release to any nation hydroxychloroquine, a drug used to treat malaria that may be helpful in treating COVID-19, Trump responded in shock, stating that he didn’t like the plan and that he would be surprised if this was the Prime Minister’s decision due to India’s strong economic ties with the United States in the trade sector. Trump stated that this course of action wouldn’t be consequence free, and that there may be retaliation in response. 

Continue Reading

Trending

Diya TV , Inc. © 2017 All Rights Reserved